MDNews - Cleveland-Akron-Canton

September/October 2013

Issue link: https://viewer.e-digitaledition.com/i/155478

Contents of this Issue

Navigation

Page 34 of 47

UH and CWRU Announce Licensing Agreement for the Development of HIV Drug Resistance Tests C ASE WESTERN RESERVE Un iversit y (C W RU) h a s signed an exclusive worldwide licensing agreement granting University Hospitals (UH) Case Medical Center rights to a series of diagnostic tests to determine drug resistance and co-receptor tropism in human immunodeficiency virus (HIV). The phenotypic and genotypic HIV tests (or assays) were invented by Eric Arts, PhD, Professor of Medicine in the Division of Infectious Diseases, Department of Medicine at Case Western Reser ve School of Medicine, and Miguel Quiñones-Mateu, PhD, Assistant Professor, Department of Pathology at the School of Medicine and Scientific Director at the University Hospitals Translational Laboratory (UHTL). The HIV assays provide a platform of diagnostic tests used by physicians and researchers to monitor the success of anti-HIV treatment by determining drug resistance and the ability of the virus to infect different cells within the patient. The HIV assays also can be used by academic and corporate researchers to develop novel strategies to block HIV replication. In July 2011, UH Case Medical Center c re ate d t he U H T L w it h the goal of advancing and further developing new molecular diagnostic methodologies originally conceived in the academic and clinical laboratories at UH Case Medical Center and Case Western Reserve. UHTL's main objective is to facilitate the development of translational research into commercial assays or products, including characterization, verification, and validation in a College of American Pathologists and Clinical Laboratory Improvement Act (CAP/CLIA) certified environment under a Good Laboratory Practice framework. The UHTL occupies 4,200 square feet of office and laboratory space, including Biosafety Level 2-plus, and was recently CAP-accredited. The first series of cellbased and molecular HIV diagnostic tests will be offered by the UHTL during the second quarter of this year. I SEPTEMBER- OCTOBER 2013 I MDNEWS.COM I MD NEWS Cleveland/Akron/Canton | 35

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Cleveland-Akron-Canton - September/October 2013